Crude OR | 95% CI | Adjusted OR | 95% CI | ||
---|---|---|---|---|---|
Age | |||||
10 to 14 | 1* | 0.74–0.89 | 1 | ||
15 to 19 | 0.81 | 0.92 | 0.78–1.09 | ||
Gender | |||||
Male | 1* | 1.17–1.41 | 1* | ||
Female | 1.29 | 1.21 | 1.05–1.39 | ||
Method into ART at facility | |||||
Transferred in from another facility | 1 | ||||
New ART patient | 0.94 | 0.85–1.04 | |||
Started IPT | |||||
No | 1* | 1 | |||
Yes | 1.19 | 1.01–1.25 | 1.04 | 0.89–1.23 | |
History of TB | |||||
No | 1* | 1 | |||
Yes | 0.55 | 0.35–0.86 | 0.73 | 0.37–1.26 | |
WHO stage | |||||
Stage 1 | 1* | 1 | |||
Stage 2 | 0.83 | 0.73–0.94 | 0.88 | 0.75–1.04 | |
Stage 3 | 0.77 | 0.67–0.91 | 0.86 | 0.72–1.03 | |
Stage 4 | 0.76 | 0.57–1.00 | 0.85 | 0.57–1.26 | |
ART initiation on same day | |||||
No | 1 | ||||
Yes | 1.21 | 0.93–1.57 | |||
Duration on ART | |||||
6 to 11 months | 1* | 1* | |||
12 to 17 months | 0.73 | 0.54–0.99 | 0.62 | 0.25–1.55 | |
18 to 24 months | 1.04 | 0.75–1.43 | 0.37 | 0.15–0.93 | |
25 months + | 0.73 | 0.58- 0.92 | 0.60 | 0.22–1.28 | |
Age at art start | |||||
0 to 9 years | 1* | 1 | |||
10 to 14 years | 0.79 | 0.72–0.87 | 0.88 | 0.74–1.04 | |
15 to 19 years | 1.44 | 1.24–1.67 | 1.30 | 0.97–1.75 | |
Pregnant during ART start | |||||
No | 1* | ||||
Yes | 1.53 | 1.18–1.98 | |||
CD4 count at last visit | |||||
CD4 < 200 | 1* | 1* | |||
CD4 > 200 | 2.45 | 2.14–2.79 | 2.53 | 2.06–3.11 | |
CD4 count at baseline | |||||
CD4 < 200 | 1* | 1* | |||
CD4 > 200 | 1.19 | 1.05–1.36 | 0.73 | 0.61–0.87 | |
Second line | |||||
No | 1* | 1* | |||
Yes | 0.38 | 0.34–0.43 | 0.41 | 0.34–0.49 |